Viewing Study NCT01045304


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-03-26 @ 11:14 PM
Study NCT ID: NCT01045304
Status: COMPLETED
Last Update Posted: 2014-01-14
First Post: 2010-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer, Metastatic View
Keywords: